By ThinkSabio #ThinkSabio Latest News
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
Announced positive initial data for IMM-1-104
FDA granted both Orphan Drug and Fast Track designations for IMM-1-104 in pancreatic cancer treatment.